chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Red raised rash appeared on upper legs, neck and face one day after vaccines given. Child given Benadryl.
Random spikes in blood pressure (up to 170 systolic) with a continuous elevated BP (140-155 systolic) when compared to average BP prior to receiving vaccination. Alcohol consumption (2-3 beers) causes these BP spikes, but does not appear until 12-48 hours after consumption. Developed symptoms similar to IBS-D. No trigger foods have been established yet.
Fever, extreme disorientation, "I must be dying" level of whole body pain, extreme headache, neck glands pain, inability to stand up, elevated heart rate, eye pain.
LLR following first AVA vaccine, given SQ. Symptoms: Disturbance of skin sensation, Swelling/mass/lump, localized superficial.
I started having muscle and joint pain in arms and legs about five and a half hours after getting the vaccine.
have had diarrhea for 2 weeks a month /diarrhea has started again; I have lost 35 pounds since September.; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (have had diarrhea for 2 weeks a month /diarrhea has started again) and WEIGHT DECREASED (I have lost 35 pounds since September.) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     Question:Describe relevant medical history/conditions, allergy, concomitant diseases and risk factor.Answer:Currently take medication for Hypothyroid and Restless Leg Syndrome.  Concurrent medical conditions included Hypothyroidism and Restless leg syndrome.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (have had diarrhea for 2 weeks a month /diarrhea has started again) (seriousness criterion hospitalization) and WEIGHT DECREASED (I have lost 35 pounds since September.) (seriousness criterion hospitalization). The patient was treated with RIFAXIMIN (XIFAXAN) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (have had diarrhea for 2 weeks a month /diarrhea has started again) and WEIGHT DECREASED (I have lost 35 pounds since September.) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had diarrhea for 2 weeks a month  It was reported that patient had numerous diagnostic tests and hospital admittance.  Patient completd Xifaxan in the month of December 2022 and it helped until Jan 14 2023 but the diarrhea has started again.  Patient had lost 35 pounds since September. Currently patient had been on medication for hypothyroid and restless leg syndrome.  Company comment  This is a spontaneous case reported by a consumer, concerning a 68 year old female patient, with no relevant medical history reported, who experienced the unexpected, serious (Hospitalization) events of Diarrhoea and weight loss on an unknown date after receiving the 1-st dose of mRNA-1273 vaccine in the covid 19 vaccination series. It was reported that the Patient had lost 35 pounds. Concurrent medical conditions included Hypothyroidism and Restless leg syndrome and was on medications. It was reported that patient had numerous diagnostic tests and hospital admissions. No details on comorbidities, risk factors, clinical course, results of labs and diagnostic tests were provided. The patient was treated with RIFAXIMIN. The events were not resolved. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jan-2023: Live follow up contains: Reporter information, patient information, product information, event information were updated.
Pulmonary embolism; Blue lips; Immediately after getting shot she couldn't breath; A spontaneous report was received from a nurse who was also a female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced difficulty breathing, blue lips, shortness of breath, and pulmonary embolism.    The patient's medical history included pulmonary embolism. No relevant concomitant medications were reported.   On 30 Dec 2020, moments prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot number 026L20A) intramuscularly for prophylaxis of COVID-19 infection.   The patient began to feel like she couldn't breathe, and her lips were blue immediately after receiving the vaccine on 30 Dec 2020. The symptoms resolved within an hour.  On 05 Jan 2021, she developed shortness of breath and experienced pulmonary embolism.  Treatment included apixaban.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, difficulty breathing, blue lips, shortness of breath, and pulmonary embolism, were not reported.; Reporter's Comments: This case concerns a female patient, nurse, of unknown age with medical history of Pulmonary embolism,  who experienced a serious, unexpected event of difficulty breathing, cyanosis and pulmonary embolism. The event of difficulty breathing and cyanosis occurred immediately and pulmonary embolism occurred after 7 days after first dose of mRNA-1273 (lot number 026L20A).  Based on the current available information and temporal association between the use of mRNA-1273 and the start of the event, a causal relationship cannot be excluded.
After 7 days from the vaccine,  I experienced pain underarm and I feel a swollen lymph node that hurts.   The following day, the vaccine site became red  about 6 inches, and itchy, and feels warm. The swelling lasted about 4 days and I still have the redness on the arm and itchiness until now that is day 4 from the first reaction.
pt stated the noc p/vax c/o pain lungs, chills, arm painful red & swollen;28OCT97 pt came to clinic area of redness &s welling measure 5x5 T98.5 o, Bp 128/70;
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant products were not provided. Reporter stated that no adverse reactions were reported by any patients.
This spontaneous report was received from a licensed nurse referring to multiple unspecified patients of unknown age and gender. The patients' concurrent conditions, medical history and concomitant therapies were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 for prophylaxis (dose, route, frequency, lot/batch # and expiration date were not reported). No adverse effects were reported. It was stated that the vaccines underwent a temperature excursion of 32 to 35 degrees Fahrenheit for 8 days (192 hours, worst case), and a temperature excursion of 47 to 77 degrees Fahrenheit for 1 hour, however it was reported that no previous temperature excursion was performed. The call was because of a "data logger". This is one of several reports received from the same source. Additional information has been requested. Sender's Comments: US-009513507-1707USA013214: US-009513507-1707USA013301: US-009513507-1707USA013303.
Within 10 minutes post vaccine, she developed severe nausea and was wretching. She was diaphoretic, color very pale. I monitored her closely for 20 to 30 minutes, at this time she stated she had begun to experience tingling in her arms and hands. At that time, I suggested to her aunt(legal guardian) that she be monitored in a more appropriate setting. We offered to call paramedics, the aunt on behalf of the patient declined, stating she would bring her to the ER.
This spontaneous report as received from a physician refers to a 13 month old male patient. On an unknown date the patient was vaccinated with 3 vaccination on one day: Hib (manufacturer unknown), Hep A (manufacturer unknown) and PREVNAR 13. The description of the adverse event was: 24 hours after vaccination the patient developed hives on his trunk, face and legs. The outcome of hives on his trunk, face and legs is unknown. Additional information has been requested.
Tossed his cookies, threw up yellow, black, thick, dark mucus; Stomach problems; Got sick with a low grade temperature of 100 degrees; Body muscles were not responding, specifically felt like his arms and legs got tired; Muscle pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 85-year-old male patient received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (Dose 2, Manufacturer unknown), for COVID-19 immunization; Covid-19 vaccine (Dose 3, Manufacturer unknown), for COVID-19 immunization. The following information was reported: VOMITING (medically significant), outcome "unknown", described as "Tossed his cookies, threw up yellow, black, thick, dark mucus"; ABDOMINAL DISCOMFORT (non-serious), outcome "unknown", described as "Stomach problems"; PYREXIA (non-serious), outcome "unknown", described as "Got sick with a low grade temperature of 100 degrees"; MUSCULAR WEAKNESS (non-serious), outcome "unknown", described as "Body muscles were not responding, specifically felt like his arms and legs got tired"; MYALGIA (non-serious), outcome "unknown", described as "Muscle pain". The patient underwent the following laboratory tests and procedures: Pyrexia: 100 degree. It was reported that, the caller states, he was called about the Pfizer Covid vaccine, booster. The caller stated that, everything was fine with all three previous shots. Stated that, when he got the second booster, he tossed his cookies, clarifies as threw up yellow, black, thick, dark mucus, stomach problems, got sick with a low grade temperature of 100 degrees, felt like he lost the next day and his body muscles were not responding, specifically felt like his arms and legs got tired. The caller declined to complete a safety report and just wanted to state his events, as informational. The caller stated that, he has Pfizer stock and felt he had a vested interested in telling his events. Caller stated that, his granddaughter told him to ask questions. Reason for no lot number of Covid vaccine: Caller was unwilling to complete the report.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
The day after, I wasn't feeling well and just rested. That evening at about 7PM, I went to stand up from the sofa and just felt pain in my lower back. I'm used to pain in my back with my conditions, but this felt a little more severe. By the next morning, I was having some trouble getting out of bed because of the pain. I immediately contacted my physical therapist and I got in to see her. I was able to work that week from home but only standing. I have not been able to sit comfortably since September 17. From there, I've been under her care and under the care of my physiatrist. Basically, there is something going on with my spine as far as inflammation. It's inflaming some parts that are already my weak spots.  By week 2, my pain became more severe. My body was in a lateral shift. My scoliosis goes one way, but my body was going the opposite. I've been in a lot of pain. I had to go on short term disability because I'm not able to stand or sit for extended periods of time. Week 2 also started with some tremors in my body. I've been having muscle twitches, but it happens in my legs, torso, and arms. Sometimes I will just feel a micro feeling of that and it will dissipate. There have been four times where shaking lasts from 20-45 minutes. I've been making some progress in PT with the back pain. It seems like even the smallest amount of exertion such as walking or even doing some PT exercises, it seems to set off my nervous system. I've never experienced back pain and shaking like this. It's completely involuntary. I tried to go back to work with reduced hours, but I'm only able to work while standing. I cannot sit and it causes pain in my lumbar spine. Today at PT, I actually had an episode of vertigo that led into the shaking episode for about 45 minutes. My physician and PT suggested I go to the ER. I went to the ER today and the shaking stopped by the time I got there. They did some blood work and that was normal, but they suggested to go see a neurologist for the shaking. My physiatrist has already ordered a lumbar MRI. My physician thinks this is necessary that I report because there's too much going on without explanation. This has been going on for 4 weeks now. I've never experienced anything like this before. For pain, my physiatrist has me taking Diclofenac/Voltaren  starting on 09/30/2022. Other treatments have been physical therapy and acupuncture specifically for these last few weeks outside of regular treatments.
Received vaccination on 2/25/2021 and on 2/26 developed puffiness under the skin which then progressed 2/29/2021 to sloughing of the top layer of skin resembling a second degree burn.     Patient believes that the injection may not have gone into the muscle but rather placed intradermally
1 week post vaccine developed SOB and cough petechiae to bilateral lower and upper extremities and back
I had my vaccine at 2:00 PM on 01/08/2021 and around 5:00 PM I felt tired and run down, by 8:00 pm I had the nausea, headache, chills, minor aches. By 11:00 pm the nausea was worse, I still had headache, chills, and so much pain in my body, I had body aches all over. My mother is a nurse and she took my temperature and it was 103 and she was concerned. She checked it every 1 and 1 1/2 hours  and it wasn't getting better, it stayed 103. My Mom gave me Tylenol. And at 8:00 am the next day my fever was back to normal range, around 99. Within 48 hours after the vaccine,  I was back to normal.
Vomiting x 2 days with decreased PO intake x 3 days after receiving J&J vaccine on 12Apr21; denies any blood in vomit/abd pain/diarrhea at this time.  1 episode vomiting today, reports comes on right after eating
SVT; This is a spontaneous report from a contactable physician. A 60-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), (At the age of 60-years) dose 1 via an unspecified route of administration, administered in Arm Right on 15Mar2021 15:00 as DOSE 1, SINGLE, dose 2 via an unspecified route of administration, administered in Arm Right on 05Apr2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included supraventricular tachycardia and History of svt. S/p ablation Onset date: 20-year Hx of sporadic episodes Pertinent details: Hx of 2 ablations- last one Nov2020. Patient was not Pregnant at the time of vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient did not receive any other medications within 2 weeks of vaccination. Patient did not diagnose with COVID Prior to vaccination. Patient did not test for COVID-19 Since the vaccination. No Allergies ware reported. The patient concomitant medications were not reported. The patient experienced supraventricular tachycardia on 25Mar2021. Patient was visited Emergency room for event. Treatment received for the adverse event: Adenosine. It was reported that patient received Treatment: B blocker for 2nd dose. Seriousness Criteria: Important medical event. The outcome of event was recovered on 2021.  Follow-up attempts are completed; information about lot/batch number cannot be obtained.; Sender's Comments: Based on the information available and a close temporal association, a possible contributory role of the suspect BNT162B2 cannot be excluded for the reported events of supraventricular tachycardia. The case will be reassessed once new information is available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate
About 10 minutes post-vaccination, while  patient was seated in our post-vaccination area, she experienced shortness of breath, light headedness, and dizziness.  She did not lose consciousness.  Then she complained of nausea and thought she might vomit.  We called 911 due to the difficulty breathing.  By the time EMS arrived (within 10 minutes), patient was breathing normally and stated that she was feeling more normal.  EMS monitored her vital signs, which were all within  normal limits.  Once the dizziness passed, she was able to leave with her  brother.  I did speak with her by phone about 3 hours later.  She stated that she was feeling fine and that it must have been a panic attack (which she said she had experienced before).
developed hives; This is a spontaneous report received from a contactable consumer (patient). An 89-year-old-female patient received 1st dose of Pfizer-BioNTech Covid-19 Vaccine BNT162B2 (Lot number: EL8982) on 21Jan2021 10:15 am on Left arm at single dose for covid-19 immunization; second dose (Lot number: EM9809) on 11Feb2021 10:15 am on Left arm at single dose for covid-19 immunization. Medical history included high blood pressure (diagnosed maybe 30 years before, ongoing), high cholesterol (diagnosed maybe 30 years before, ongoing), low thyroid (it's low thyroid and was diagnosed maybe 25 years before, ongoing). For Concomitant products, Caller states she's on a lot of medications. Caller said that she and her daughter had developed hives after receiving the Pfizer COVID-19 vaccine. She wanted to know if that could be a reaction from the vaccine. She also wanted to know how long it would last. Caller wanted to know if the hives she has can be transmitted to her daughter. Caller states hives started about 2 or 3 months before, she received the vaccine in Feb2021 and hives started in Feb2021 (as reported). States she is on medications (Caller states she's taking Tagamet and there is another name for it but that is the generic that she's been taking. States she's been taking it since 2 months ago) so it's improved. Clarified with caller that she experienced hives after the first dose of the Pfizer Covid-19 vaccine (as reported). No Emergency Room visit. Caller states she went to the doctor's office for hives. Outcome of the event was recovering.  No follow-up attempts are needed. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021384101 same reporter/event/drug, different patient
Itchy rash started on arms and migrated to upper body and lower extremities ~3 weeks post vaccination.  Linear wheals or geometric shapes of slight erythematous and edematous plaques on arms, abdomen, back and lower extremities that are associated with pruritus continued for approximately  one month.  Unknown if related to vaccine.  Treated with cetirizine.
Case number PHEH2013US020542 is an initial spontaneous report received from a nurse on 30 SEP 2013 with the follow-up received on 14 JAN 2014. This report refers to a 31-year-old female patient. On 27 SEP 2013, she was vaccinated intramuscularly into deltoid with FLUVIRIN 2013/2014 (batch number: 1308401, expiry date: MAR 2014). It was reported that before vaccination, FLUVIRIN was placed in the shipping container at room temperature for 72 hours and later administered to the patient (incorrect storage of vaccine). No adverse event was reported following this medication error.  Follow-up received from nurse on 14 JAN 2014. Site of vaccine administration was updated.
Pt recvd MMR vax 9MAY91 & approx 1 hr following  pt devel sz w/a fever; pt was hospitalized for sepsis work-up  & was discharged as well 24 hrs later; no further details were provided;
Information has been received from a registered pharmacist concerning a 59 year old female patient with asthma and heart disease, allergy to sulfa, quinolones and tetracycline who on 01-JUN-2010 was vaccinated SC with a 0.65 ml dose of ZOSTAVAX (Merck) (Lot# 665524/1374Y, exp 25-MAR-2011). Concomitant therapies included: digoxin (manufacturer unknown) and LAMICTAL. On an unspecified date the patient had an injection site reaction that initially was the size of a dime but was not the size of a quarter. The area was swollen and red but not painful. Pharmacist could not remember if the patient described it as being a rash. The patient sought medical attention by calling the pharmacist. There was no lab diagnostic test. The patient was taking BENADRYL to treat her symptoms. At the time of report the patient's status was not recovered. Additional information has been requested.
Patient's mom called pharmacy 08/20/17 at 5:47 PM to report reaction. Stated on 8/17 patient was experiencing soreness, fevers, and discoloration at that was actively spreading as far as 2 inches below the injection site. She was taking pictures and recording times to monitor symptom improvement. Patient was taken to hospital and diagnosed with cellulitis that originated at site of injection. She was prescribed antibiotics which she picked up at a different pharmacy and mom states symptoms seem to be improving but she still has chills. They just moved to the area and currently have no primary doctor to report to.
Pt recvd vax 6AUG92 & on 4SEP92 recvd 2nd dose of vax & the day following 2nd dose pt devel lightheadedness, SOB, palpitations & diaphoresis; No further details were provided;